Decode Nearly Doubles Revenues in Q2 - Personalized Medicine

As posted recently, more efforts are going towards educating the public and physicians on how to to use the genomic information generated. The company is located in Iceland and has working partnerships with companies like Illumina, Roche, and Merck and one other location in Illinois. One other related story talks about a high ranking individual finding his own issues by use of their tests.

Bottom line here is that the genetics testing business is ramping up and where the investors are going. BD

NEW YORK (GenomeWeb News) – Decode Genetics reported after the close of the market on Wednesday that its second-quarter revenues nearly doubled to $15 million from $7.6 million year over year. The company’s R&D spending was cut 44.8 percent to $8 million from $14.5 million year over year, while its SG&A expenses edged up 4.4 percent to $7.1 million from $6.8 million.